Logo Internet-AI colonne_top.png, 439B

Members



content_top.png, 479B

> Top story

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND ORIBASE PHARMA

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND ORIBASE PHARMA

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND ORIBASE PHARMA 20/07/2011

CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have applications in the oncology field.

page(s)
CHEM-X-INFINITY RELEASES A PYRAZOLE PROPIONAMIDE LIBRARY 02/12/2009

CHEM-X-INFINITY released a new focused library centered on the pyrazole propionamide scaffold. Many strategies for the synthesis of pyrazoles are described in the literature. We used an original cyclisation to obtain pyrazole propionamides that could have applications in the GPCR field and for the discovery of new NSAIDs.

CHEM-X-INFINITY RELEASES A QUINOLINE CARBOXAMIDE LIBRARY 16/10/2009

CHEM-X-INFINITY is pleased to present a new diverse library centered around the quinoline carboxamide scaffold. This small and versatile heterocycle offers many interaction possibilities with diverse receptors as peptide and amine GPCRs or ion channels. The library is a good collection for first intention screenings.

CHEM-X-INFINITY PRESENTS A CNS MODEL AND A CNS LIBRARY 03/08/2009

CHEM-X-INFINITY presents its CNS model, which was developed in collaboration with Centro de Investigación Príncipe Felipe, Valencia, Spain. The model was used to propose a diverse selection of CNS predicted compounds from Chem-X-Infinity’s libraries.

CHEM-X-INFINITY PRESENTS A NEW NUCLEOTIDE INTERACTING LIBRARY 21/04/2009

CHEM-X-INFINITY is pleased to present an aminopyrazole carboxamide focused library. The compounds could have applications against proteins that interact with nucleotides, like kinases, phosphodiesterases and reverse transcriptases.

page(s)
footer_top.png, 537B